Article Versions Notes

Venugopala KN, Al-Shar’i NA, Dahabiyeh LA, Hourani W, Deb PK, Pillay M, Abu-Irmaileh B, Bustanji Y, Chandrashekharappa S, Tratrat C, et al. Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives. Antibiotics. 2022; 11(7):831. https://doi.org/10.3390/antibiotics11070831

Venugopala, Katharigatta N., Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Wafa Hourani, Pran Kishore Deb, Melendhran Pillay, Bashaer Abu-Irmaileh, Yasser Bustanji, Sandeep Chandrashekharappa, Christophe Tratrat, and et al. 2022. "Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives" Antibiotics 11, no. 7: 831. https://doi.org/10.3390/antibiotics11070831

Venugopala, K. N., Al-Shar’i, N. A., Dahabiyeh, L. A., Hourani, W., Deb, P. K., Pillay, M., Abu-Irmaileh, B., Bustanji, Y., Chandrashekharappa, S., Tratrat, C., Attimarad, M., Nair, A. B., Sreeharsha, N., Shinu, P., Haroun, M., Kandeel, M., Balgoname, A. A., Venugopala, R., & Morsy, M. A. (2022). Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives. Antibiotics, 11(7), 831. https://doi.org/10.3390/antibiotics11070831